BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31866191)

  • 1. Measles, rubella, mumps and Toxoplasma gondii antibodies in saliva of vaccinated students of schools and universities in São Paulo City, Brazil.
    Sampaio BCF; Rodrigues JP; Meireles LR; Andrade Junior HF
    Braz J Infect Dis; 2020; 24(1):51-57. PubMed ID: 31866191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
    Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil, 1996.
    dos Santos BA; Stralioto SM; Siqueira MM; Ranieri TS; Bercini M; Schermann MT; Wagner MB; Silveira TR
    Rev Panam Salud Publica; 2006 Nov; 20(5):299-306. PubMed ID: 17316487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
    J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of salivary antibodies for determining seropositivity to measles, rubella, and mumps in children and adults].
    Garrido Redondo M; Blanco Quirós A; Garrote Adrados JA; Tellería Orriols JJ; Arranz Sanz E
    An Esp Pediatr; 1997 Nov; 47(5):499-504. PubMed ID: 9586291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay.
    Perry KR; Brown DW; Parry JV; Panday S; Pipkin C; Richards A
    J Med Virol; 1993 Jul; 40(3):235-40. PubMed ID: 8355022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and efficacy of Hoshino strain of mumps vaccine in Iran; two years study.
    Avijgan M; Hafizi M; Moghni M; Kheiri S; Esteghamati A; Sarikhani S
    East Afr J Public Health; 2011 Jun; 8(2):88-91. PubMed ID: 22066292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saliva collection and detection of anti- T. gondii antibodies of low-income school-age children as a learning strategy on hygiene, prevention and transmission of toxoplasmosis.
    Macre MS; Meireles LR; Sampaio BFC; Andrade Júnior HF
    Rev Inst Med Trop Sao Paulo; 2019 Sep; 61():e48. PubMed ID: 31531626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010.
    Ang LW; Lai FY; Tey SH; Cutter J; James L; Goh KT
    Epidemiol Infect; 2013 Aug; 141(8):1721-30. PubMed ID: 22999024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.
    Saffar H; Khalifeloo M; Saffar MJ; Abdollahi A; Parsaei MR; Ghorbani GR; Salarvand S; Aarabi M
    BMC Infect Dis; 2021 Mar; 21(1):305. PubMed ID: 33765968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
    PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Measles Antibodies in São José do Rio Preto, São Paulo, Brazil: A serological survey model.
    Estofolete CF; Milhim BHGA; França CCG; Silva GCDD; Augusto MT; Terzian ACB; Zini N; Durigon EL; Oliveira DBL; Massad E; Nogueira ML
    Sci Rep; 2020 Mar; 10(1):5179. PubMed ID: 32198469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
    Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A
    J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University.
    Keshavarz M; Nicknam MH; Tebyanian M; Shahkarami MK; Izad M
    Iran J Allergy Asthma Immunol; 2016 Jun; 15(3):244-50. PubMed ID: 27424140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.
    Feiterna-Sperling C; Brönnimann R; Tischer A; Stettler P; Durrer P; Gaedicke G
    Pediatr Infect Dis J; 2005 Dec; 24(12):1083-8. PubMed ID: 16371870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of maternal measles-rubella immunization on the 12-month-old infant's immune response to measles-mumps-rubella vaccine immunogenicity.
    Saffar MJ; Ajami A; Khalilian AR; Saffar H
    Eur J Clin Microbiol Infect Dis; 2009 Jul; 28(7):845-7. PubMed ID: 19229565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.